Bausch + Lomb

Glaucoma, dry eye drugs center of pharmaceutical opportunitiesThe pharma drought is coming to a close. After decades of same-old medications for glaucoma and ocular surface disease, a series of new agents with new mechanisms of action (MOA) are moving toward marketing approval.
B + L places focus on innovation in pharma, surgical, vision careBausch + Lomb (B + L) is more than one of the oldest eye care companies in the industry. It is also one of the broadest, with portfolios in contact lenses, consumer eye products, cataract surgery, intraocular lenses, retina surgery, and a wide range of ophthalmic pharmaceutical products.
Phaco technology evolves over timeFifty years after the idea for phacoemulsification came to Charles Kelman, MD, few would have predicted that surgical platforms would evolve to where they are today.
Next-generation phaco system design improves stability, reduces energyLos Angeles ophthalmologist Mitchell Shultz, MD, shares some of his clinical experience with a next-generation phacoemulsification platform (Stellaris Elite, Bausch + Lomb). The new platform received 510(k) clearance from the FDA in April.
5 reasons to upgrade patients from monovision to multifocalsMany optometrists use the “if it aint broke, don’t fix it” excuse for not fitting multifocals. It is time for ODs to get comfortable with multifocal contact lenses and the opportunity they provide our practices as well as the ability they give us to meet modern patient demands.
10 tips to enhance scleral contact lens success
10 tips to enhance scleral contact lens successImprove your scleral fitting skills and your patients’ quality of life
Fit multifocal lenses for older and younger patients
Fit multifocal lenses for older and younger patientsBecoming an experienced multifocal contact lens fitter allows ODs to address visual needs for two patient populations: presbyopes (and emerging presbyopes) and myopic children. Knowing when to choose a soft multifocal vs. a gas permeable or specialty design will increase fitting success for the OD as well as patient satisfaction.
Sizing up daily disposable contact lensesMost ODs could list all the missing items in their contact lens supply line. They could construct a wish list of products they would like to see available in the future. On days when we find ourselves ransacking the contact lens trial room, ODs may think technology is moving too slowly. Perhaps it’s time for some needed perspective.
Preparing your patient for PRKPhotorefractive keratectomy (PRK) was the original excimer laser procedure approved by the FDA—and is still a safe and effective treatment of refractive errors. PRK has the benefits of no-flap creation; therefore, there is no risk of flap complications.
Developing contact lens technology at Global Contact Lens ForumAt its fourth annual gathering at Vision Expo East, the Global Contact Lens Forum addressed developing technologies with research and development (R&D) scientists, evidence-based eye care, and contact lens practice settings.